Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Potential value of human thrombomodulin and DAF expression for coagulation control in pig‐to‐human xenotransplantation

Potential value of human thrombomodulin and DAF expression for coagulation control in... Miwa Y, Yamamoto K, Onishi A, Iwamoto M, Yazaki S, Haneda M, Iwasaki K, Liu D, Ogawa H, Nagasaka T, Uchida K, Nakao A, Kadomatsu K, Kobayashi T. Potential value of human thrombomodulin and DAF expression for coagulation control in pig‐to‐human xenotransplantation. Xenotransplantation 2010; 17: 26–37. © 2010 John Wiley & Sons A/S. Abstract: Background: Problems of coagulation disorder remain to be resolved in pig‐to‐primate xenotransplantation. Molecular incompatibilities in the coagulation systems between pigs and humans, such as the thrombomodulin (TM)‐protein C system or direct prothrombinase activity, have been suggested as possible causes. Coagulation and complement activation are closely related to each other. The purpose of this study was to elucidate the protective effects on the coagulation system of the expression of human TM and decay accelerating factor (hDAF) (for inhibition of complement activation) in pig endothelial cells. Methods: Human aortic endothelial cells (HAEC), porcine aortic endothelial cells (PAEC), hDAF‐expressing PAEC (hDAF‐PAEC), hDAF/Endo‐β‐galactosidase C‐expressing PAEC (hDAF/EndoGalC‐PAEC), hTM‐expressing PAEC (hTM‐PAEC), hDAF/hTM expressing‐PAEC (hDAF/hTM‐PAEC), and hDAF/EndoGalC/hTM‐expressing PAEC (hDAF/EndoGalC/hTM‐PAEC) were used in this study. Coagulation activity was examined by clotting, activated protein C (APC), and thrombin generation assay. Results: A large difference was observed in clotting time of human plasma when exposed to PAEC (170 s) and HAEC (1020 s). hTM expression on PAEC was proven to produce a comparable level of APC to that produced by HAEC, which prolonged the clotting time, though not to the level of HAEC. Pretreatment with human sera considerably shortened the clotting time in PAEC (80 s). hDAF‐PAEC significantly inhibited such a shortening of clotting time by reductions in tissue factor expression and thrombin generation. Thrombin generation through direct prothrombinase activity, which was detected only in PAEC, could be suppressed by hTM expression. Suppression of antibody binding and complement activation improved clotting time not in PAEC, but in PAEC expressing hTM. Conclusions: In addition to effective suppression of antibody‐induced complement activation, hTM expression in PAEC may be essential for regulating procoagulant activity in xenotransplantation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Xenotransplantation Wiley

Potential value of human thrombomodulin and DAF expression for coagulation control in pig‐to‐human xenotransplantation

Download PDF
12 pages

Loading next page...
 
/lp/wiley/potential-value-of-human-thrombomodulin-and-daf-expression-for-mXH7PGidLl

References (55)

Publisher
Wiley
Copyright
© 2010 John Wiley & Sons A/S
ISSN
0908-665X
eISSN
1399-3089
DOI
10.1111/j.1399-3089.2009.00555.x
pmid
20149186
Publisher site
See Article on Publisher Site

Abstract

Miwa Y, Yamamoto K, Onishi A, Iwamoto M, Yazaki S, Haneda M, Iwasaki K, Liu D, Ogawa H, Nagasaka T, Uchida K, Nakao A, Kadomatsu K, Kobayashi T. Potential value of human thrombomodulin and DAF expression for coagulation control in pig‐to‐human xenotransplantation. Xenotransplantation 2010; 17: 26–37. © 2010 John Wiley & Sons A/S. Abstract: Background: Problems of coagulation disorder remain to be resolved in pig‐to‐primate xenotransplantation. Molecular incompatibilities in the coagulation systems between pigs and humans, such as the thrombomodulin (TM)‐protein C system or direct prothrombinase activity, have been suggested as possible causes. Coagulation and complement activation are closely related to each other. The purpose of this study was to elucidate the protective effects on the coagulation system of the expression of human TM and decay accelerating factor (hDAF) (for inhibition of complement activation) in pig endothelial cells. Methods: Human aortic endothelial cells (HAEC), porcine aortic endothelial cells (PAEC), hDAF‐expressing PAEC (hDAF‐PAEC), hDAF/Endo‐β‐galactosidase C‐expressing PAEC (hDAF/EndoGalC‐PAEC), hTM‐expressing PAEC (hTM‐PAEC), hDAF/hTM expressing‐PAEC (hDAF/hTM‐PAEC), and hDAF/EndoGalC/hTM‐expressing PAEC (hDAF/EndoGalC/hTM‐PAEC) were used in this study. Coagulation activity was examined by clotting, activated protein C (APC), and thrombin generation assay. Results: A large difference was observed in clotting time of human plasma when exposed to PAEC (170 s) and HAEC (1020 s). hTM expression on PAEC was proven to produce a comparable level of APC to that produced by HAEC, which prolonged the clotting time, though not to the level of HAEC. Pretreatment with human sera considerably shortened the clotting time in PAEC (80 s). hDAF‐PAEC significantly inhibited such a shortening of clotting time by reductions in tissue factor expression and thrombin generation. Thrombin generation through direct prothrombinase activity, which was detected only in PAEC, could be suppressed by hTM expression. Suppression of antibody binding and complement activation improved clotting time not in PAEC, but in PAEC expressing hTM. Conclusions: In addition to effective suppression of antibody‐induced complement activation, hTM expression in PAEC may be essential for regulating procoagulant activity in xenotransplantation.

Journal

Xenotransplantation – Wiley

Published: Jan 1, 2010

There are no references for this article.